论文部分内容阅读
最近美国食品与药品管理局(FDA)批准了Relenza(Zanamivir)用于流行性感冒的治疗,Relenza是一类新的抗病毒药物(神经氨酸酶抑制剂)中获准用于流感治疗的第一种药物。 Relenza是自1993年以来获准用于流感治疗的第一种药物。同时,它也是目前唯一的一种治疗甲型和乙型两种流感的药物。
Recently the United States Food and Drug Administration (FDA) approved Relenza (Zanamivir) for the treatment of influenza, Relenza is the first of a new class of antiviral drugs (neuraminidase inhibitors) approved for flu treatment Kind of medicine Relenza is the first drug approved for flu treatment since 1993. At the same time, it is currently the only drug that treats both type A and type B flu.